ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC

Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC

New launches and R&D pipeline bolster Sun Pharma's long-term growth outlook
Sun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launches and pipeline advancements, including Unloxcyt and Leqselvi, are poised to drive long-term growth. Analysts maintai
Announcement as on 10 November 2025

Sun Pharma’s US innovative drug sales surpass generics for the first time
Sun Pharma's U.S. innovative medicine sales have surpassed generics for the first time, driven by key products like Ilumya and Cequa. The launch of Leqselvi for alopecia has been well-received, with further growth anticipated from upcoming launches like Un
Announcement as on 06 November 2025

Sun Pharma's US innovative drug sales surpass generics for first time
Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on medicines. The company is evaluating its current footprint and considering localization options, though the tariff's impact on its pr
Announcement as on 05 November 2025

Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on margins
Sun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi launch costs, weak Taro performance, and high R&D spend as margin drags, even as domestic and specialty segments co
Announcement as on 04 November 2025

Company Announcement

Announcement as on 31 October 2025

Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |

SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals

Moving Averages for Sun Pharma Advanced Research Company Limited

  • 5Day Average: 148.4
  • 12Day Average: 136.05
  • 20Day Average: 128.56
  • 50Day Average: 129.44
  • 100Day Average: 132.46
  • 150Day Average: 133.35
  • 200Day Average: 137.83

SPARC Indicators & signals

Indicator MACD (12,26,9)

139.28, 132.54, 3.39
Indicator MACD is in positive zone

Indicator ADX (14)

11.27, 31.64, 25.23
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Apr 2026 148.01 147.05 to 153.69 -2.94% 0.45 times
16 Thu Apr 2026 152.50 150.70 to 156.90 1.14% 0.57 times
15 Wed Apr 2026 150.78 144.40 to 157.40 5.89% 1.35 times
13 Mon Apr 2026 142.39 118.68 to 145.79 -4.01% 0.38 times
10 Fri Apr 2026 148.34 144.00 to 153.24 1.48% 0.82 times
09 Thu Apr 2026 146.17 134.41 to 153.00 7.35% 4.08 times
08 Wed Apr 2026 136.16 127.09 to 138.40 7.74% 1 times
07 Tue Apr 2026 126.38 121.47 to 132.50 3.07% 0.67 times
06 Mon Apr 2026 122.62 120.57 to 124.06 -1.16% 0.37 times
02 Thu Apr 2026 124.06 116.12 to 124.75 3.09% 0.38 times
01 Wed Apr 2026 120.34 118.23 to 122.30 4.74% 0.38 times
30 Mon Mar 2026 114.89 113.91 to 121.56 -4.96% 1.15 times

Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

 

Back to top